Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug-resistant Enterobacteriaceae (MRE) during international travel, we aimed to determine, among French travellers attending a consultation for travel medicine, their level of knowledge about the risk of acquiring MRE. Among 191 adults enrolled in the study, only 10% of travellers were aware of the risk of becoming a carrier of MRE during travel, and 87% did not understand the difference between being colonized with MRE, and having a clinical infection with MRE. Consultations for travel medicine could be an opportunity to deliver specific information about the risks of acquiring MRE.
Introduction
Antibiotic resistance among Gram-negative bacteria is an emerging problem worldwide, mainly with the diffusion of extended spectrum beta-lactamase, plasmid-encoded cephalosporinases and carbapenemases-producing Enterobacteriaceae. These strains often show multi-resistance and are now diffusing worldwide in the community setting, outside of the hospital. Travel in areas endemic for multidrug-resistant Enterobacteriaceae (MRE) has been identified as a risk factor for the acquisition of MRE. [1] [2] [3] [4] [5] Faecal colonization with MRE is very frequent among travellers to tropical regions, with a risk ranging from 20 to 70%, especially among those visiting the South Asian continent. 2, 3, 5 Moreover, antibiotic use could favour proliferation of MRE by disrupting the intestinal microbiota balance, and the use of antibiotics for travel diarrhoea was associated with a 4-fold increase in the risk of acquiring MRE, whereas travel diarrhoea itself was only associated with a 2-fold increase in risk. 2, 3, 6 Taken together, these elements suggest that informing the public about the risk of acquiring MRE during international travel could represent a preventive measure against the spread of MRE in France. The French public has been made aware of multidrug-resistant (MDR) bacteria through a media campaign conducted by the French National Health Insurance each winter since autumn 2002, explaining that the use of antibiotics is associated with a risk of resistance. 7 However, this campaign did not mention the risk of acquiring MDR bacteria during travel. Thus, since no routine measures are implemented to raise the awareness of the general public about the risk of acquiring MRE during international travel, we aimed to assess, among persons attending a consultation for travel medicine and international vaccines, their level of knowledge regarding (i) the risk of acquiring MRE, (ii) preventive behaviours and (iii) the need to inform health professionals that they had recently travelled if they require medical care after their return.
Methods
A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The study was approved by the institutional ethics committee of Reims University Hospital under the number 2016-15.
The questionnaire was completed before the planned travel and recorded information on the participant's age, gender, level of education, travel destination, type of accommodation (hostel, with relatives, camping, with locals), place where meals were intended to be taken (restaurant, with locals), type of travel (business, tourist, backpacker style, visit to relatives and friends etc.), knowledge of the definition of MDR bacteria, knowledge of the factors associated with acquiring MDR bacteria, consumption of antibiotics during previous travel, having already taken antibiotics for self-treatment in case of travel diarrhoea (note: doxycycline prescribed for antimalarial prophylaxis was not included), awareness of the need to inform health professionals about the recent trip in case of health problems after return, perceived need for more information about MDR bacteria (yes/no), desired source of such information (delivered by their general practitioner or by the vaccination centre).
The term 'multidrug-resistant bacteria' (MDR bacteria) was used in this study because we felt that it was clearer than the term 'MRE' for the general public, and it is also the term used in the prevention campaigns in the French media. The questions about knowledge were designed to be as simple as possible, with closed answers ('yes', 'no', 'don't know'). The travellers answered the questionnaires before seeing the physician. The questionnaire was tested on a small group who did not work in the health sector to ensure that it was comprehensible.
Descriptive analysis was performed. Qualitative variables are described as number (percentage) and quantitative variables as mean 6 standard deviation.
Results
All 191 adults who attended a travel medicine and international vaccination consultation during the study period were enrolled. No eligible patient refused to participate. The main characteristics of the study population are summarized in Table 1 . Slightly more than half the patients were female (n ¼ 107; 56%); the mean age was 40.5 6 14.6 years and 72% (n ¼ 138) had a highschool diploma or higher education. Only 11.5% (n ¼ 22) were employed in the health sector.
For 39% (n ¼ 74) of travellers, the trip under preparation was their first time abroad. The most frequent destinations were sub-Saharan Africa (62%; n ¼ 115) and South America (20%; n ¼ 38). A visit to relatives was the main purpose of travel in 44% (n ¼ 83), followed by tourism (39%; n ¼ 74). No medical tourism was reported.
Most travellers planned to eat with locals (75%; n ¼ 142). Only 10% (n ¼ 10) had used antibiotics during prior trips, and 3% (n ¼ 6) planned to bring antibiotics for their present trip.
Although 64% (n ¼ 122) had heard of MDR bacteria, they did not understand the meaning of MDR bacteria (70%; n ¼ 133), and 87% (n ¼ 165) could not tell the difference between being colonized with MDR bacteria, and having a clinical infection with MDR (Table 2) . Furthermore, only 10% (n ¼ 19) of travellers were aware of the risk of becoming a carrier of MDR bacteria during travel. However, they cited diarrhoea (52%; n ¼ 98), lack of hand hygiene (78%; n ¼ 145), the area visited (33%; n ¼ 60) and hospitalization (54%; n ¼ 102) as risk factors for acquiring MDR bacteria. The majority of travellers (69%; n ¼ 131) knew they had to inform health professionals that they had recently travelled in case they required medical care after their return. A high proportion (87%; n ¼ 161) claimed that they felt the need for more information about MDR bacteria, and wanted it to be delivered by their general practitioner (75%; n ¼ 120) or by the vaccination centre (54%; n ¼ 86).
Discussion
To the best of our knowledge, this is the first study to assess the level of knowledge among French travellers regarding the risk of acquiring MRE (termed MDR bacteria in our questionnaire). We observed that although most French travellers were informed of bacterial resistance, and knew that the use of antibiotics increased the risk of bacterial resistance, they did not understand its significance, and overall, had low awareness of the risk of contracting MRE during international travel. Indeed, only 10% of participants were aware of this risk.
Besides the awareness that hand hygiene and antibiotic consumption are risks factors for acquiring MDR bacteria, which was generally high and in line with institutional prevention campaigns in France, other risks such as the area of travel, diarrhoea and hospitalization during travel were less well known. Furthermore, not knowing whether bathing in the sea or drinking hot tea was risk factor or not illustrates that strategies to avoid MRE acquisition are not well known in a high proportion of French travellers. Our results are in line with one prospective qualitative Swedish study evaluating travellers' knowledge of antibiotic resistance and the risk of becoming an MRE carrier. 8 Only few travellers in that study were aware of the risk of carriage of MRE and the potential consequences for society and for themselves. 8 The poor state of knowledge observed in our study could be related in part to the low number of travellers going to South Asia, which is associated with the highest risk of acquiring MRE. 2, 6 The type of travel could be another explanation.
Indeed, 54% of the travellers in our study had hotels, and allinclusive resorts have been reported to significantly associated with a lower risk of MRE acquisition than all other types of accommodation, although our questionnaire did not distinguish between hotels and all-inclusive resorts. 3 Although the majority of travellers knew they had to inform health professionals about their recent trip in case of medical care after their return, it is likely that they did not know this information could be related to the risk of MRE acquisition. Contact isolation is recommended by national guidelines for patients admitted to hospital abroad within the previous 12 months. 9, 10 However, there are no clear recommendations concerning unhospitalized travellers returning from areas with a high endemicity of MRE and who are admitted to hospital on their return, or who require antibiotics. Moreover, the time delay during which the MRE risk should be considered after the traveller's return is not well defined. Indeed, one study reported that more than 95% of international travellers who acquired MRE during travel were free of them 3 months after their return. 3 Finally, a high rate of travellers claimed to need more information about MRE, with a preference for receiving this information from their general practitioners or during a consultation for travel medicine. However, the level of knowledge among French general practitioners' about the risk of acquiring MRE during travel is unknown. Therefore, consultation for travel medicine in international vaccination centres could be an ideal opportunity to deliver specific information about the risks of acquiring MRE during travel and preventive measures. However, such consultations are currently limited to travellers requiring yellow fever or Japanese encephalitis vaccines in France.
This study has some limitations. First, this was a singlecentre study and therefore, the study sample may not be representative of French travellers in France. Secondly, improvement in the knowledge should have been evaluated with a debriefing questionnaire after the subject's return.
In conclusion, travel medicine consultations should be generalized to all travellers given that awareness of the risk among travellers is key to avoid acquisition of MRE during travel, and the further spread of MRE in France.
